Locations:
SearchAdvertisement
Retrospective study finds acceptable cancer control among most histologic subtypes with intravesical therapy
Revolutionizing pediatric urology with a new, less invasive approach
Findings put into focus the reality of work-related injuries and physician burnout
First-ever procedure restores patient’s health
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Enfortumab vedotin plus pembrolizumab benefited patients, regardless of biomarker expression
What updated techniques, counseling and a changing workforce could mean
Treatment involved checkpoint inhibitor, surgery and intravesical therapy
Applications, outcomes and untapped potential
Retrospective study shows SGLT-2 inhibitors may lead to worse urologic outcomes
Early, individualized diagnosis and comprehensive management key to preserving fertility
Advertisement
Advertisement